JP2013527167A5 - - Google Patents

Download PDF

Info

Publication number
JP2013527167A5
JP2013527167A5 JP2013508152A JP2013508152A JP2013527167A5 JP 2013527167 A5 JP2013527167 A5 JP 2013527167A5 JP 2013508152 A JP2013508152 A JP 2013508152A JP 2013508152 A JP2013508152 A JP 2013508152A JP 2013527167 A5 JP2013527167 A5 JP 2013527167A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
nicotine
composition according
levulinic acid
levulinate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013508152A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013527167A (ja
JP5981416B2 (ja
Filing date
Publication date
Priority claimed from US12/769,335 external-priority patent/US20110268809A1/en
Application filed filed Critical
Publication of JP2013527167A publication Critical patent/JP2013527167A/ja
Publication of JP2013527167A5 publication Critical patent/JP2013527167A5/ja
Application granted granted Critical
Publication of JP5981416B2 publication Critical patent/JP5981416B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013508152A 2010-04-28 2011-04-26 ニコチン含有医薬組成物 Active JP5981416B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12/769,335 2010-04-28
US12/769,335 US20110268809A1 (en) 2010-04-28 2010-04-28 Nicotine-Containing Pharmaceutical Compositions
PCT/US2011/033928 WO2011139684A2 (en) 2010-04-28 2011-04-26 Nicotine-containing pharmaceutical compositions

Publications (3)

Publication Number Publication Date
JP2013527167A JP2013527167A (ja) 2013-06-27
JP2013527167A5 true JP2013527167A5 (https=) 2014-05-29
JP5981416B2 JP5981416B2 (ja) 2016-08-31

Family

ID=44626142

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013508152A Active JP5981416B2 (ja) 2010-04-28 2011-04-26 ニコチン含有医薬組成物

Country Status (5)

Country Link
US (1) US20110268809A1 (https=)
EP (1) EP2563330A2 (https=)
JP (1) JP5981416B2 (https=)
CN (1) CN102933199A (https=)
WO (1) WO2011139684A2 (https=)

Families Citing this family (119)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10244793B2 (en) 2005-07-19 2019-04-02 Juul Labs, Inc. Devices for vaporization of a substance
AT507187B1 (de) 2008-10-23 2010-03-15 Helmut Dr Buchberger Inhalator
EP2672847B1 (de) 2011-02-11 2015-04-22 Batmark Limited Inhalatorkomponente
SE535587C2 (sv) 2011-03-29 2012-10-02 Chill Of Sweden Ab Produkt innehållande ett fritt nikotinsalt och en ej vattenlöslig påse
US20130017259A1 (en) * 2011-07-06 2013-01-17 The Parkinson's Institute Compositions and Methods for Treatment of Symptoms in Parkinson's Disease Patients
US9474303B2 (en) 2011-09-22 2016-10-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9629392B2 (en) 2011-09-22 2017-04-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US20130078307A1 (en) 2011-09-22 2013-03-28 Niconovum Usa, Inc. Nicotine-containing pharmaceutical composition
US9084439B2 (en) 2011-09-22 2015-07-21 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9907748B2 (en) 2011-10-21 2018-03-06 Niconovum Usa, Inc. Excipients for nicotine-containing therapeutic compositions
US20130177646A1 (en) * 2012-01-05 2013-07-11 Mcneil Ab Solid Nicotine-Comprising Dosage Form with Reduced Organoleptic Disturbance
WO2013119627A1 (en) * 2012-02-06 2013-08-15 Kraft Foods Global Brands Llc Oral delivery products including three-dimensional objects
US9763928B2 (en) 2012-02-10 2017-09-19 Niconovum Usa, Inc. Multi-layer nicotine-containing pharmaceutical composition
US10517530B2 (en) 2012-08-28 2019-12-31 Juul Labs, Inc. Methods and devices for delivering and monitoring of tobacco, nicotine, or other substances
US20140255452A1 (en) 2013-03-11 2014-09-11 Niconovum Usa, Inc. Method and apparatus for differentiating oral pouch products
US10279934B2 (en) 2013-03-15 2019-05-07 Juul Labs, Inc. Fillable vaporizer cartridge and method of filling
WO2014182736A1 (en) * 2013-05-06 2014-11-13 Ploom, Inc. Nicotine salt formulations for aerosol devices and methods thereof
WO2014201432A1 (en) 2013-06-14 2014-12-18 Ploom, Inc. Multiple heating elements with separate vaporizable materials in an electric vaporization device
US10357054B2 (en) 2013-10-16 2019-07-23 R.J. Reynolds Tobacco Company Smokeless tobacco pastille
WO2015084544A1 (en) * 2013-12-05 2015-06-11 Ploom, Inc. Nicotine liquid formulations for aerosol devices and methods thereof
US10159282B2 (en) 2013-12-23 2018-12-25 Juul Labs, Inc. Cartridge for use with a vaporizer device
US10076139B2 (en) 2013-12-23 2018-09-18 Juul Labs, Inc. Vaporizer apparatus
USD842536S1 (en) 2016-07-28 2019-03-05 Juul Labs, Inc. Vaporizer cartridge
US9549573B2 (en) 2013-12-23 2017-01-24 Pax Labs, Inc. Vaporization device systems and methods
USD825102S1 (en) 2016-07-28 2018-08-07 Juul Labs, Inc. Vaporizer device with cartridge
US10058129B2 (en) 2013-12-23 2018-08-28 Juul Labs, Inc. Vaporization device systems and methods
US20160366947A1 (en) 2013-12-23 2016-12-22 James Monsees Vaporizer apparatus
DE202014011261U1 (de) 2013-12-23 2018-11-13 Juul Labs Uk Holdco Limited Systeme für eine Verdampfungsvorrichtung
US11478021B2 (en) 2014-05-16 2022-10-25 Juul Labs, Inc. Systems and methods for aerosolizing a vaporizable material
US20150335070A1 (en) 2014-05-20 2015-11-26 R.J. Reynolds Tobacco Company Electrically-powered aerosol delivery system
US9896429B2 (en) 2014-05-27 2018-02-20 R.J. Reynolds Tobacco Company Nicotine salts, co-crystals, and salt co-crystal complexes
CN113754634A (zh) 2014-05-27 2021-12-07 R.J.雷诺兹烟草公司 烟碱盐、共晶体和盐共晶体络合物
US10508096B2 (en) 2014-05-27 2019-12-17 R.J. Reynolds Tobacco Company Nicotine salts, co-crystals, and salt co-crystal complexes
US11019840B2 (en) 2014-07-02 2021-06-01 R.J. Reynolds Tobacco Company Oral pouch products
US10959456B2 (en) 2014-09-12 2021-03-30 R.J. Reynolds Tobacco Company Nonwoven pouch comprising heat sealable binder fiber
EA201700155A1 (ru) * 2014-10-20 2017-10-31 Товарищество С Ограниченной Ответственностью "Фармацевтическая Компания "Ромат" Фармацевтическая композиция для лечения туберкулеза
GB2535427A (en) * 2014-11-07 2016-08-24 Nicoventures Holdings Ltd Solution
EP3821735B1 (en) 2014-12-05 2024-11-20 Juul Labs, Inc. Calibrated dose control
US20160157515A1 (en) 2014-12-05 2016-06-09 R.J. Reynolds Tobacco Company Smokeless tobacco pouch
US9968125B2 (en) 2015-01-09 2018-05-15 Philip Morris Products S.A. Nicotine—diketopiperazine microparticle formulations and methods of making the same
JP2018511355A (ja) 2015-01-28 2018-04-26 クロノ セラピューティクス インコーポレイテッドChrono Therapeutics Inc. 薬剤送達方法及びシステム
AU2016228779A1 (en) 2015-03-12 2017-09-07 Chrono Therapeutics Inc. Craving input and support system
US10154689B2 (en) 2015-06-30 2018-12-18 R.J. Reynolds Tobacco Company Heat generation segment for an aerosol-generation system of a smoking article
US20170071248A1 (en) 2015-09-16 2017-03-16 Sansa Corporation (Barbados) Inc. System and Method for Controlling the Harshness of Nicotine-Based Dry Powder Formulations
US11224594B2 (en) 2015-09-16 2022-01-18 Philip Morris Products S.A. Nicotine formulations and methods of making and using the same
US9585835B1 (en) 2015-09-16 2017-03-07 Sansa Corporation (Barbados) Inc. Inhalable nicotine formulations and methods of making and using the same
US10149844B2 (en) 2015-09-16 2018-12-11 Philip Morris Products S.A. Inhalable nicotine formulations, and methods of making and using thereof
GB2542838B (en) 2015-10-01 2022-01-12 Nicoventures Trading Ltd Aerosol provision system
PL4059365T3 (pl) 2015-11-24 2024-07-01 R. J. Reynolds Tobacco Company Zasilany elektrycznie system dostarczania aerozolu
DK3379952T3 (da) * 2015-11-25 2024-01-08 Reynolds Tobacco Co R Nikotinsalte, co-krystaller og salt-co-krystalkomplekser
US20170165252A1 (en) 2015-12-10 2017-06-15 Niconovum Usa Inc. Protein-enriched therapeutic composition
HUE063028T2 (hu) * 2015-12-24 2023-12-28 Philip Morris Products Sa Ízesített nikotinpor
CN108697152B (zh) * 2015-12-30 2022-01-11 下一代实验室有限责任公司 包含合成尼古丁的尼古丁替代疗法产品
EP3413960B1 (en) 2016-02-11 2021-03-31 Juul Labs, Inc. Fillable vaporizer cartridge and method of filling
EA039727B1 (ru) 2016-02-11 2022-03-04 Джуул Лэбз, Инк. Надежно прикрепляющиеся картриджи для испарительных устройств
JP2019512470A (ja) * 2016-02-29 2019-05-16 ニコゲン リミテッド ニコチン配合物及びエアロゾル
US10405582B2 (en) 2016-03-10 2019-09-10 Pax Labs, Inc. Vaporization device with lip sensing
US10143687B2 (en) 2016-04-11 2018-12-04 Neurocea, LLC Compositions and methods for treatment related to fall and fall frequency in neurodegenerative diseases
US10292977B2 (en) 2016-04-11 2019-05-21 Neurocea, LLC Compositions and methods for treatment related to fall and fall frequency in neurodegenerative diseases
USD849996S1 (en) 2016-06-16 2019-05-28 Pax Labs, Inc. Vaporizer cartridge
USD848057S1 (en) 2016-06-23 2019-05-07 Pax Labs, Inc. Lid for a vaporizer
USD836541S1 (en) 2016-06-23 2018-12-25 Pax Labs, Inc. Charging device
USD851830S1 (en) 2016-06-23 2019-06-18 Pax Labs, Inc. Combined vaporizer tamp and pick tool
US10617151B2 (en) 2016-07-21 2020-04-14 Rai Strategic Holdings, Inc. Aerosol delivery device with a liquid transport element comprising a porous monolith and related method
US10602775B2 (en) 2016-07-21 2020-03-31 Rai Strategic Holdings, Inc. Aerosol delivery device with a unitary reservoir and liquid transport element comprising a porous monolith and related method
US11660403B2 (en) 2016-09-22 2023-05-30 Juul Labs, Inc. Leak-resistant vaporizer device
US10080387B2 (en) 2016-09-23 2018-09-25 Rai Strategic Holdings, Inc. Aerosol delivery device with replaceable wick and heater assembly
EP3565617A1 (en) 2017-01-06 2019-11-13 Chrono Therapeutics Inc. Transdermal drug delivery devices and methods
US11717017B2 (en) 2017-04-24 2023-08-08 Swedish Match North Europe Ab Flavoured moist oral pouched nicotine product comprising triglyceride
PL3681865T3 (pl) 2017-09-05 2026-02-23 R. J. Reynolds Tobacco Company Sole, kokryształy i kompleksy kokryształów soli nikotyny
USD887632S1 (en) 2017-09-14 2020-06-16 Pax Labs, Inc. Vaporizer cartridge
US10786010B2 (en) 2017-12-15 2020-09-29 Rai Strategic Holdings, Inc. Aerosol delivery device with multiple aerosol delivery pathways
US10555558B2 (en) 2017-12-29 2020-02-11 Rai Strategic Holdings, Inc. Aerosol delivery device providing flavor control
EP3801732A4 (en) 2018-05-29 2022-04-27 Morningside Venture Investments Limited METHODS AND SYSTEMS FOR DRUG DELIVERY
WO2019239356A1 (en) 2018-06-15 2019-12-19 R. J. Reynolds Tobacco Company Purification of nicotine
US20200077703A1 (en) 2018-09-11 2020-03-12 Rai Strategic Holdings, Inc. Wicking element for aerosol delivery device
US12397141B2 (en) 2018-11-16 2025-08-26 Morningside Venture Investments Limited Thermally regulated transdermal drug delivery system
US12213510B2 (en) 2019-09-11 2025-02-04 Nicoventures Trading Limited Pouched products with enhanced flavor stability
US12342847B2 (en) 2019-09-11 2025-07-01 Nicoventures Trading Limited Oral product with cellulosic flavor stabilizer
JP2023505351A (ja) 2019-12-09 2023-02-08 ニコベンチャーズ トレーディング リミテッド 口腔用組成物のための薬剤
US12491250B2 (en) 2019-12-09 2025-12-09 Nicoventures Trading Limited Oral composition with nanocrystalline cellulose
US11883527B2 (en) 2019-12-09 2024-01-30 Nicoventures Trading Limited Oral composition and method of manufacture
CA3159473A1 (en) 2019-12-09 2021-06-17 Savannah JOHNSON Fleece for oral product with releasable component
US20210169138A1 (en) 2019-12-09 2021-06-10 Nicoventures Trading Limited Fibrous fleece material
US12310959B2 (en) 2019-12-09 2025-05-27 Nicoventures Trading Limited Oral compositions with reduced water content
US12520867B2 (en) 2019-12-09 2026-01-13 Nicoventures Trading Limited Buffered oral compositions
JP2023505799A (ja) 2019-12-09 2023-02-13 ニコベンチャーズ トレーディング リミテッド フリース材料を含む多孔性パウチ内の経口製品
US12439952B2 (en) 2019-12-09 2025-10-14 Nicoventures Trading Limited Moist oral compositions
US11672862B2 (en) 2019-12-09 2023-06-13 Nicoventures Trading Limited Oral products with reduced irritation
JP2023505800A (ja) 2019-12-09 2023-02-13 ニコベンチャーズ トレーディング リミテッド 刺激応答性パウチ
BR112022010899A2 (pt) 2019-12-09 2022-09-06 Nicoventures Trading Ltd Produto oral com componente dissolúvel
US12151023B2 (en) 2019-12-09 2024-11-26 Nicoventures Trading Limited Oral composition with beet material
US11617744B2 (en) 2019-12-09 2023-04-04 Nico Ventures Trading Limited Moist oral compositions
US11793230B2 (en) 2019-12-09 2023-10-24 Nicoventures Trading Limited Oral products with improved binding of active ingredients
US12137723B2 (en) 2019-12-09 2024-11-12 Nicoventures Trading Limited Oral products with active ingredient combinations
EP4072317A1 (en) 2019-12-09 2022-10-19 Nicoventures Trading Limited Pouched products with heat sealable binder
US12171872B2 (en) 2019-12-09 2024-12-24 Nicoventures Trading Limited Oral compositions and methods of manufacture
US12433321B2 (en) 2019-12-09 2025-10-07 Nicoventures Trading Limited Oral composition with beet material
EP4072516A1 (en) 2019-12-09 2022-10-19 Nicoventures Trading Limited Oral product comprising a cannabinoid
US11969502B2 (en) 2019-12-09 2024-04-30 Nicoventures Trading Limited Oral products
US12550928B2 (en) 2019-12-09 2026-02-17 Nicoventures Trading Limited Liquid oral composition
US12599160B2 (en) 2019-12-09 2026-04-14 Nicoventures Trading Limited Lipid-containing oral composition
US12439949B2 (en) 2019-12-09 2025-10-14 Nicoventures Trading Limited Oral compositions with reduced water activity
US11826462B2 (en) 2019-12-09 2023-11-28 Nicoventures Trading Limited Oral product with sustained flavor release
US11872231B2 (en) 2019-12-09 2024-01-16 Nicoventures Trading Limited Moist oral product comprising an active ingredient
US11889856B2 (en) 2019-12-09 2024-02-06 Nicoventures Trading Limited Oral foam composition
AU2021289162A1 (en) 2020-06-08 2023-02-09 Nicoventures Trading Limited Effervescent oral composition comprising an active ingredient
WO2022103638A1 (en) 2020-11-16 2022-05-19 Orcosa Inc. Cannabinoids in the treatment of autism spectrum disorder
US11672761B2 (en) 2020-11-16 2023-06-13 Orcosa Inc. Rapidly infusing platform and compositions for therapeutic treatment in humans
US11839602B2 (en) 2020-11-25 2023-12-12 Nicoventures Trading Limited Oral cannabinoid product with lipid component
US20220232881A1 (en) 2021-01-28 2022-07-28 Nicoventures Trading Limited Method for sealing pouches
MX2023015529A (es) 2021-06-25 2024-03-05 Nicoventures Trading Ltd Productos orales y metodo de fabricacion.
KR20240036696A (ko) 2021-07-30 2024-03-20 니코벤처스 트레이딩 리미티드 미세결정질 셀룰로오스를 포함하는 에어로졸 발생 기재
CA3131364A1 (en) * 2021-09-20 2023-03-20 Apotex Inc. Novel salts of nintedanib and crystalline forms thereof
CA3233375A1 (en) 2021-09-30 2023-04-06 Michael Zawadzki Oral product with a basic amine and an ion pairing agent
US20230148660A1 (en) 2021-11-15 2023-05-18 Nicoventures Trading Limited Products with enhanced sensory characteristics
CA3247270A1 (en) 2022-04-06 2023-10-12 Nicoventures Trading Limited PRODUCTS IN BAGS WITH HEAT-SEALABLE BINDER
KR102848894B1 (ko) * 2022-10-26 2025-08-21 한국원자력연구원 합성 니코틴의 감별 방법
CN115997965A (zh) * 2023-02-09 2023-04-25 东莞市吉纯生物技术有限公司 一种尼古丁缓释型口含烟及其制备方法

Family Cites Families (122)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2033909A (en) 1934-12-19 1936-03-17 Niacet Chemicals Corp Manufacture of calcium levulinate
US3877468A (en) 1970-07-22 1975-04-15 Leo Ab Chewable tobacco substitute composition
US3901248A (en) 1970-07-22 1975-08-26 Leo Ab Chewable smoking substitute composition
US3845217A (en) 1972-11-16 1974-10-29 Helsingborg L Ab Buffered smoking substitute compositions
US4284809A (en) 1979-04-02 1981-08-18 The Upjohn Company 13,14-Didehydro-inter-oxa-19-oxo-PGF1 compounds
GB8301659D0 (en) 1983-01-21 1983-02-23 Leo Ab Smoking substitutes
US4655231A (en) 1984-01-09 1987-04-07 Advanced Tobacco Products, Inc. Snuff and preparation thereof
US4597961A (en) 1985-01-23 1986-07-01 Etscorn Frank T Transcutaneous application of nicotine
US4800903A (en) 1985-05-24 1989-01-31 Ray Jon P Nicotine dispenser with polymeric reservoir of nicotine
GB8615676D0 (en) 1986-06-26 1986-07-30 Stoppers Co Ltd Nicotine containing lozenge
US4830028A (en) 1987-02-10 1989-05-16 R. J. Reynolds Tobacco Company Salts provided from nicotine and organic acid as cigarette additives
DE3884246T2 (de) * 1987-02-10 1994-03-03 Reynolds Tobacco Co R Zigarette.
IL86170A (en) 1987-05-01 1992-12-01 Elan Transdermal Ltd Preparations and compositions comprising nicotine for percutaneous administration
US5834011A (en) 1988-02-19 1998-11-10 The Regents Of The University Of California Method for aiding in the reduction of incidence of tobacco smoking
US5004610A (en) 1988-06-14 1991-04-02 Alza Corporation Subsaturated nicotine transdermal therapeutic system
US5154927A (en) 1989-01-19 1992-10-13 Wm. Wrigley Jr. Company Gum composition containing dispersed porous beads containing active chewing gum ingredients and method
US5525351A (en) 1989-11-07 1996-06-11 Dam; Anders Nicotine containing stimulant unit
US5512306A (en) 1992-06-19 1996-04-30 Pharmica Ab Smoking substitute
SE8904295D0 (sv) 1989-12-21 1989-12-21 Pharmacia Ab Smoking substitute
US5031646A (en) 1990-01-16 1991-07-16 R. J. Reynolds Tobacco Company Cigarette
US5167242A (en) 1990-06-08 1992-12-01 Kabi Pharmacia Aktiebolaq Nicotine-impermeable container and method of fabricating the same
US5147654A (en) 1990-07-23 1992-09-15 Alza Corporation Oral osmotic device for delivering nicotine
US5110605A (en) 1990-08-21 1992-05-05 Oramed, Inc. Calcium polycarbophil-alginate controlled release composition and method
GB9200047D0 (en) 1992-01-03 1992-02-26 Univ Alberta Nicotine-containing nasal spray
US6024097A (en) 1992-02-20 2000-02-15 J Mom Trust Product for assisting a smoker in giving up the habit
US6098632A (en) 1992-11-25 2000-08-08 Pharmacia & Upjohn Ab Nicotine-impermeable container and method of fabricating the same
US6602892B1 (en) 1993-06-10 2003-08-05 David P. L. Sachs Methods for nicotine replacement dosage determination
DE69422925T2 (de) 1993-07-09 2000-08-17 Cygnus, Inc. Verfahren und vorrichtung für die transdermale oder transbuccale therapeutische verabreichung von nikotinsubstituten
US5549906A (en) 1993-07-26 1996-08-27 Pharmacia Ab Nicotine lozenge and therapeutic method for smoking cessation
US5362496A (en) 1993-08-04 1994-11-08 Pharmetrix Corporation Method and therapeutic system for smoking cessation
SE9303574D0 (sv) 1993-11-01 1993-11-01 Kabi Pharmacia Ab Composition for drug delivery and method the manufacturing thereof
IT1274034B (it) 1994-07-26 1997-07-14 Applied Pharma Res Composizioni farmaceutiche a base di gomma da masticare e procedimento per la loro preparazione
US5723477A (en) 1994-11-10 1998-03-03 Sibia Neurosciences, Inc. Modulators of acetylcholine receptors
US5604231A (en) 1995-01-06 1997-02-18 Smith; Carr J. Pharmaceutical compositions for prevention and treatment of ulcerative colitis
US5583140A (en) 1995-05-17 1996-12-10 Bencherif; Merouane Pharmaceutical compositions for the treatment of central nervous system disorders
US5811126A (en) 1995-10-02 1998-09-22 Euro-Celtique, S.A. Controlled release matrix for pharmaceuticals
ATE260646T1 (de) 1996-04-16 2004-03-15 Novartis Consumer Health Sa Schnell zerfallende orale dosierungsform
US6166048A (en) 1999-04-20 2000-12-26 Targacept, Inc. Pharmaceutical compositions for inhibition of cytokine production and secretion
GB9614902D0 (en) 1996-07-16 1996-09-04 Rhodes John Sustained release composition
DE19646392A1 (de) 1996-11-11 1998-05-14 Lohmann Therapie Syst Lts Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
US5811442A (en) 1997-02-21 1998-09-22 Bencherif; Merouane Pharmaceutical compositions for the treatment of conditions associated with decreased blood flow
US6024981A (en) 1997-04-16 2000-02-15 Cima Labs Inc. Rapidly dissolving robust dosage form
US7214686B2 (en) 1997-06-30 2007-05-08 Targacept, Inc. Pharmaceutical compositions and methods for effecting dopamine release
US20030176467A1 (en) 1997-09-25 2003-09-18 Sven Andersson Nicotine compositions
US6268386B1 (en) 1998-06-25 2001-07-31 Marshall Anlauf Thompson Nicotine beverage
US6234169B1 (en) 1998-08-14 2001-05-22 Arthur Slutsky Inhaler
US6344222B1 (en) 1998-09-03 2002-02-05 Jsr Llc Medicated chewing gum delivery system for nicotine
US6358060B2 (en) 1998-09-03 2002-03-19 Jsr Llc Two-stage transmucosal medicine delivery system for symptom relief
US20020098264A1 (en) 1998-11-27 2002-07-25 Cherukuri Subraman R. Medicated chewing gum delivery system for nicotine
US6596298B2 (en) 1998-09-25 2003-07-22 Warner-Lambert Company Fast dissolving orally comsumable films
SE9803986D0 (sv) 1998-11-23 1998-11-23 Pharmacia & Upjohn Ab New compositions
GB9826192D0 (en) 1998-12-01 1999-01-20 Controlled Theraputics Scotlan Oral transmucosal delivery
US7163705B2 (en) 1998-12-15 2007-01-16 Wm. Wrigley Jr. Company Coated chewing gum product and method of making
ATE288256T1 (de) 1999-01-14 2005-02-15 Noven Pharma Dermale zusammensetzungen
US6248363B1 (en) 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US7374779B2 (en) 1999-02-26 2008-05-20 Lipocine, Inc. Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
US6090401A (en) 1999-03-31 2000-07-18 Mcneil-Ppc, Inc. Stable foam composition
US6773716B2 (en) 1999-04-06 2004-08-10 Wm. Wrigley Jr. Company Over-coated chewing gum formulations
US6426090B1 (en) 1999-04-06 2002-07-30 Wm. Wrigley Jr. Company Over-coated product including tableted center and medicament
US6355265B1 (en) 1999-04-06 2002-03-12 Wm. Wrigley Jr. Company Over-coated chewing gum formulations
US6322806B1 (en) 1999-04-06 2001-11-27 Wm. Wrigley Jr. Company Over-coated chewing gum formulations including tableted center
US6248760B1 (en) 1999-04-14 2001-06-19 Paul C Wilhelmsen Tablet giving rapid release of nicotine for transmucosal administration
US20010016593A1 (en) 1999-04-14 2001-08-23 Wilhelmsen Paul C. Element giving rapid release of nicotine for transmucosal administration
US6583160B2 (en) 1999-04-14 2003-06-24 Steve Smith Nicotine therapy method and oral carrier for assuaging tobacco-addiction
US6319510B1 (en) 1999-04-20 2001-11-20 Alayne Yates Gum pad for delivery of medication to mucosal tissues
GB9911037D0 (en) 1999-05-13 1999-07-14 Micap Limited Nicotine delivery service
US6799576B2 (en) 1999-07-16 2004-10-05 Aradigm Corporation System for effecting smoking cessation
US8256433B2 (en) 1999-07-16 2012-09-04 Aradigm Corporation Systems and methods for effecting cessation of tobacco use
US20080138398A1 (en) 1999-07-16 2008-06-12 Aradigm Corporation Dual release nicotine formulations, and systems and methods for their use
US6322828B1 (en) 1999-09-13 2001-11-27 Deseret Laboratories, Inc. Process for manufacturing a pharmaceutical chewing gum
US6660754B1 (en) 2000-02-15 2003-12-09 Smithkline Beecham Corporation Method for reducing or eliminating smoking
US7115297B2 (en) 2000-02-22 2006-10-03 Suzanne Jaffe Stillman Nutritionally fortified liquid composition with added value delivery systems/elements/additives
US7067116B1 (en) 2000-03-23 2006-06-27 Warner-Lambert Company Llc Fast dissolving orally consumable solid film containing a taste masking agent and pharmaceutically active agent at weight ratio of 1:3 to 3:1
CA2359813C (en) 2000-10-24 2008-04-22 Richard L. Jones Nicotine mucosal spray
SE0102197D0 (sv) 2001-06-20 2001-06-20 Pharmacia Ab New product and use and manufacture thereof
US6585997B2 (en) 2001-08-16 2003-07-01 Access Pharmaceuticals, Inc. Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
US7208186B2 (en) 2001-09-18 2007-04-24 Spi Pharma, Inc. Chewing gum formulation and method of making the same
CN1602193A (zh) 2001-12-10 2005-03-30 约瑟夫·罗伯特·奈特 用烟碱处理的饮料
SE0104388D0 (sv) 2001-12-27 2001-12-27 Pharmacia Ab New formulation and use and manufacture thereof
US20030159702A1 (en) 2002-01-21 2003-08-28 Lindell Katarina E.A. Formulation and use manufacture thereof
PL372290A1 (en) 2002-02-07 2005-07-11 Pharmacia Corporation Pharmaceutical dosage form for mucosal delivery
CA2475773A1 (en) 2002-02-20 2003-09-04 Pharmacia & Upjohn Company Azabicyclic compounds with alfa7 nicotinic acetylcholine receptor activity
US7105173B1 (en) 2002-03-21 2006-09-12 Rolling Kenneth J Nicotine replacement applique
US20040101543A1 (en) 2002-03-22 2004-05-27 John Liu Nicotine-containing oral dosage form
US7767698B2 (en) 2002-06-03 2010-08-03 Mcneil Ab Formulation and use thereof
US8216609B2 (en) 2002-08-05 2012-07-10 Torrent Pharmaceuticals Limited Modified release composition of highly soluble drugs
US7135484B2 (en) 2002-08-14 2006-11-14 Abbott Laboratories Azabicyclic compounds are central nervous system active agents
EP1549154A1 (en) 2002-09-24 2005-07-06 Gumlink A/S Degradable chewing gum polymer
DE60228341D1 (de) 2002-09-24 2008-09-25 Gumlinck As Biologisch abbaubarer kaugummi enthaltend wenigstens ein biologish abbaubares polymer mit hochmolekularem gewicht
US20060246174A1 (en) 2002-09-24 2006-11-02 Lone Andersen Gum base
EP1549153B1 (en) 2002-09-24 2012-12-05 Gumlink A/S Chewing gum having improved release of chewing gum ingredients
US6886557B2 (en) * 2002-10-31 2005-05-03 Hewlett-Packard Development Company, L.P. Inhalation device and method for delivering variable amounts of different components
ES2285233T3 (es) * 2002-12-20 2007-11-16 Niconovum Ab Un material en particulas que contiene nicotina y celulosa microcristalina fisicamente y quimicamente estable.
EP1449525A1 (en) 2003-02-20 2004-08-25 Cross Chem Llc chewing gum in the form of multi-layer tablets
US20040182403A1 (en) 2003-02-28 2004-09-23 Sven-Borje Andersson Container comprising nicotine and the use and manufacture thereof
CN100381083C (zh) 2003-04-29 2008-04-16 韩力 一种非可燃性电子喷雾香烟
EP1648421B1 (en) 2003-07-24 2017-10-18 GlaxoSmithKline LLC Orally dissolving films
DK1663168T3 (da) 2003-09-08 2009-06-08 Mcneil Ab Nikotinformuleringer og anvendelse deraf
US20050123502A1 (en) 2003-10-07 2005-06-09 Chan Shing Y. Nicotine containing oral compositions
DE602004022708D1 (de) 2003-12-02 2009-10-01 Fertin Pharma As Nikotin-abgabeprodukt und herstellungsverfahren
WO2006004646A1 (en) * 2004-06-28 2006-01-12 Nektar Therapeutics Aerosol formulation comprising nicotine salt
CN101090713A (zh) 2004-11-30 2007-12-19 费尔廷制药公司 尼古丁口香糖对使用者提供快速缓解的方法
WO2006100075A2 (en) 2005-03-22 2006-09-28 Niconovum Ab Use of an artificial sweetener to enhance absorption of nicotine
US8323683B2 (en) 2005-05-18 2012-12-04 Mcneil-Ppc, Inc. Flavoring of drug-containing chewing gums
DE602006010542D1 (de) 2005-06-01 2009-12-31 Fertin Pharma As Verfahren zur herstellung eines nikotinzuführenden produkts
US20070134169A1 (en) * 2005-12-11 2007-06-14 Rabinoff Michael D Methods for smoking cessation or alcohol cessation or other addiction cessation
US9402809B2 (en) 2006-03-16 2016-08-02 Niconovum Usa, Inc. Snuff composition
WO2007104574A2 (en) * 2006-03-16 2007-09-20 Niconovum Ab Chewing gum compositions providing rapid release of nicotine
CN101528199B (zh) * 2006-03-16 2013-05-29 尼科诺瓦姆股份公司 改良的鼻烟组合物
US20070269492A1 (en) 2006-05-16 2007-11-22 Per Steen New product and use and manufacture thereof
US20070269386A1 (en) 2006-05-16 2007-11-22 Per Steen New product and use and manufacture thereof
US8642016B2 (en) 2006-07-21 2014-02-04 Jsrnti, Llc Medicinal delivery system, and related methods
CN101516426A (zh) 2006-09-27 2009-08-26 尼克诺姆股份公司 定向用途
MX2009005671A (es) * 2006-12-01 2009-06-08 Cima Labs Inc Forma de dosificacion de nicotina transmucosal oral.
CN101563071A (zh) * 2006-12-01 2009-10-21 赛福伦公司 尼古丁经口粘膜剂型
US20080286341A1 (en) 2007-05-16 2008-11-20 Sven-Borje Andersson Buffered coated nicotine containing products
US20080286340A1 (en) 2007-05-16 2008-11-20 Sven-Borje Andersson Buffered nicotine containing products
US20080292683A1 (en) 2007-05-24 2008-11-27 Monosolrx, Llc. Film shreds and delivery system incorporating same
US20090004248A1 (en) 2007-06-29 2009-01-01 Frank Bunick Dual portion dosage lozenge form
US20090081291A1 (en) 2007-09-26 2009-03-26 Gin Jerry B Sustained Release Dosage Forms For Delivery of Agents to an Oral Cavity of a User
EP2268639A2 (en) 2008-05-22 2011-01-05 Teva Pharmaceutical Industries Ltd. Varenicline tosylate, an intermediate in the preparation process of varenicline l-tartrate
US20100018539A1 (en) 2008-07-28 2010-01-28 Paul Andrew Brinkley Smokeless tobacco products and processes

Similar Documents

Publication Publication Date Title
JP2013527167A5 (https=)
ES2656322T3 (es) Composiciones farmacéuticas que contienen nicotina
WO2013101897A3 (en) Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid
JP6013346B2 (ja) 即時使用可能なケトロラク製剤
MX2015011896A (es) Formulacion de liberacion sostenida de mosapride que proporciona efectos farmacologicos y clinicos con administracion una vez al dia.
JP2012255026A5 (https=)
JP2011137020A5 (https=)
JP2011068653A5 (https=)
WO2011139684A3 (en) Nicotine-containing pharmaceutical compositions
JP2011201907A5 (https=)
JP2010518122A5 (https=)
RU2016151697A (ru) Расправляемая удерживаемая в желудке лекарственная форма
MX2010010647A (es) Proceso para preparar formulaciones de dabigatran para administracion oral.
HRP20201316T1 (hr) Novi modulatori receptora sfingozin-fosfata
JP2010090168A5 (https=)
RU2014121065A (ru) Бензойная кислота, производные бензойной кислоты и конъюгаты гетероарилкарбоновой кислоты с гидроморфоном, пролекарства, способы получения и их применение
NZ606123A (en) Use of binders for manufacturing storage stable formulations
NZ601595A (en) Oral formulations and lipophilic salts of methylnaltrexone
RU2013136350A (ru) Фармацевтическая композиция, содержащая опиоидный агонист и секвестрированный антагонист
NZ595467A (en) Sublingual pharmaceutical composition comprising a neutral oil
ES2704987T3 (es) Composiciones farmacéuticas para terapia de combinación
RU2007149044A (ru) Твердые лекарственные формы наркотических лекарственных средств с улучшенным всасыванием при трансбуккальном введении
HRP20171742T4 (hr) 2,4,6-trifluor-n-[6-(1-metilpiperidin-4-karbonil)piridin-2-il]benzamid, namijenjen liječenju migrene oralnom ili intravenskom primjenom
HRP20100373T4 (hr) Upotreba kombinacije morfina s najmanje jednim opijatnim antagonistom u liječenju ovisnosti o opijatima i u sprječavanju neoralne zloupotrebe opijata kod ovisnika opijatima
JP2016537364A5 (https=)